Ameriprise Financial Inc Clearside Biomedical, Inc. Transaction History

Ameriprise Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.35 - $2.88 $52,031 - $111,000	-38,542 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.72 - $5.72 $1,360 - $2,860	500 Added 1.31%	38,542 $106,000
Q3 2021 Nov 15, 2021	BUY	$4.83 - $7.2 $183,742 - $273,902	38,042 New	38,042 $228,000
Q2 2018 Aug 14, 2018	SELL	$8.91 - $14.54 $648,612 - $1.06 Million	-72,796 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $405,473 - $1.04 Million	72,796 New	72,796 $782,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.